Diversified Healthcare Trust (DHC)
(Delayed Data from NSDQ)
$3.78 USD
-0.22 (-5.50%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $3.78 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Diversified Healthcare Trust falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,410 | 1,284 | 1,383 | 1,632 | 1,040 |
Cost Of Goods | 1,174 | 1,109 | 1,092 | 1,236 | 489 |
Gross Profit | 236 | 175 | 291 | 396 | 551 |
Selling & Adminstrative & Depr. & Amort Expenses | 339 | 268 | 323 | 409 | 454 |
Income After Depreciation & Amortization | -103 | -94 | -31 | -13 | 97 |
Non-Operating Income | 22 | 282 | 468 | 81 | 1 |
Interest Expense | 192 | 209 | 256 | 201 | 180 |
Pretax Income | -273 | -21 | 181 | -133 | -83 |
Income Taxes | 0 | 1 | 1 | 1 | 0 |
Minority Interest | 0 | 0 | 5 | 5 | 5 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | -20 | 6 | 0 | 0 | 0 |
Income From Cont. Operations | -294 | -16 | 180 | -134 | -83 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -294 | -16 | 175 | -139 | -88 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 192 | 154 | 246 | 258 | 385 |
Depreciation & Amortization (Cash Flow) | 296 | 248 | 277 | 271 | 288 |
Income After Depreciation & Amortization | -103 | -94 | -31 | -13 | 97 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 238.84 | 238.31 | 237.97 | 237.74 | 237.60 |
Diluted EPS Before Non-Recurring Items | -1.23 | -0.07 | 0.73 | -0.59 | -0.37 |
Diluted Net EPS (GAAP) | -1.23 | -0.07 | 0.73 | -0.59 | -0.37 |
Fiscal Year end for Diversified Healthcare Trust falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 371.39 | 370.78 | 361.53 | 356.52 | 346.22 |
Cost Of Goods | 304.07 | 307.60 | 303.41 | 298.43 | 286.23 |
Gross Profit | 67.33 | 63.17 | 58.12 | 58.09 | 59.99 |
SG&A, R&D, and Dept/Amort Expenses | 82.99 | 89.93 | 90.71 | 79.03 | 93.02 |
Income After SG&A, R&D, and Dept/Amort Expenses | -15.66 | -26.76 | -32.59 | -20.94 | -33.03 |
Non-Operating Income | -11.02 | -3.64 | 0.47 | 3.24 | 5.13 |
Interest Expense | 58.70 | 57.58 | 48.85 | 47.76 | 47.38 |
Pretax Income | -85.38 | -87.97 | -79.90 | -65.45 | -75.28 |
Income Taxes | 0.17 | 0.19 | 0.07 | 0.19 | 0.22 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | -12.31 | 1.90 | -22.60 | -0.15 | 2.93 |
Income From Cont. Operations | -97.86 | -86.26 | -102.56 | -65.78 | -72.57 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -97.86 | -86.26 | -102.56 | -65.78 | -72.57 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 239.33 | 239.19 | 239.18 | 238.89 | 238.68 |
Diluted EPS Before Non-Recurring Items | -0.41 | -0.36 | -0.43 | -0.28 | -0.30 |
Diluted Net EPS (GAAP) | -0.41 | -0.36 | -0.43 | -0.28 | -0.30 |